The Beneficial Effects of Adjunctive Recombinant Human Interleukin-2 for Multidrug Resistant Tuberculosis

Archives of Medical Science - Poland
doi 10.5114/aoms.2015.52362
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

New England Journal of Medicine
Medicine
2009English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

A Performance Evaluation of MTBDRplus Version 2 for the Diagnosis of Multidrug-Resistant Tuberculosis

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2016English

Trends in Multidrug-Resistant Tuberculosis

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2008English

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection With Multidrug-Resistant Enterobacteriaceae

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2016English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Multidrug Resistant Tuberculosis: Understanding the Past for the Better Future

International Journal of Medicine and Public Health
2016English

Multidrug and Extensively Drug-Resistant Tuberculosis

Infectious Disease Clinics of North America
Infectious DiseasesMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy